• Gap26 Connexin 43 Mimetic Peptide: Unlocking Intercellular S

  2026-07-03

  Gap26 offers precise, reversible control over gap junction-mediated communication, empowering researchers to dissect calcium signaling, ATP release, and mitochondrial transfer in advanced cellular and animal models. This article demystifies protocol design, troubleshooting, and translational use-cases that make Gap26 indispensable for vascular, neurobiological, and inflammation research.

• Geneticin, G-418 Sulfate: Mechanisms, Glutamine Metabolism,

  2026-07-03

  Explore how G418 Sulfate (Geneticin) reshapes genetic engineering and antiviral research, with a scientific deep-dive into its ribosomal inhibition pathway and an innovative perspective on glutamine metabolism's role in cell line development.

• Targeting Glutamine Metabolism in HSCs Reduces Liver Fibrosi

  2026-07-02

  The referenced study demonstrates that inhibiting glutamine metabolism in hepatic stellate cells (HSCs), particularly by modulating SIRT4 and glutamate dehydrogenase (GDH) activity, leads to significant attenuation of liver fibrosis. These findings provide a mechanistic basis for antifibrotic therapies targeting metabolic pathways, offering new avenues for translational research in chronic liver disease.

• AMPK-JAK2/STAT3 Axis in M1 Macrophage Polarization and Obesi

  2026-07-02

  This study reveals that AMPK downregulation drives M1 macrophage polarization and airway inflammation in obesity-related asthma, while AMPK activation attenuates these effects via the JAK2/STAT3 pathway. The findings highlight AMPK as a mechanistic link and potential therapeutic target for asthma phenotypes associated with metabolic dysfunction.

• Carbapenemase Gene Dynamics in Enterobacter cloacae: New Ins

  2026-07-01

  This study provides a detailed molecular and epidemiological characterization of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from Guangdong, China. By analyzing the distribution, transmissibility, and resistance profiles of these genes, the research advances our understanding of multidrug resistance mechanisms and highlights urgent surveillance needs.

• Evaluating Cefoperazone's Antibacterial Activity Versus New

  2026-07-01

  This article analyzes a landmark comparative study of N-formimidoyl thienamycin (MK0787) and several advanced β-lactam antibiotics—including cefoperazone—against multidrug-resistant clinical isolates. The study’s rigorous methodology and findings inform nuanced assay design and antibiotic selection for research targeting gram-negative resistance and β-lactamase stability.

• Applied Protocols with CHIR-99021: Stem Cell Differentiation

  2026-06-30

  CHIR-99021 (CT99021) delivers exceptional selectivity for GSK-3 inhibition, empowering researchers to fine-tune pluripotency, lineage commitment, and vasculogenesis in advanced stem cell platforms. This guide details optimized workflows, troubleshooting tips, and applied insights—bridging foundational research and practical execution.

• Bafilomycin A1: V-ATPase Inhibitor Powering Lysosomal Resear

  2026-06-30

  Bafilomycin A1, a selective V-ATPase inhibitor, enables precise manipulation of intracellular pH and lysosomal function, critical for dissecting cell death pathways and disease models. This guide delivers robust workflows, troubleshooting strategies, and actionable insights for maximizing reproducibility and discovery in cell biology and cancer research.

• ARCA Cy5 EGFP mRNA (5-moUTP): Advancing Quantitative mRNA De

  2026-06-29

  Explore the advanced features of ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, and its transformative impact on quantitative mRNA delivery and localization assays in mammalian cells. This article provides deep scientific insights and practical workflow guidance for researchers in mRNA delivery system research.

• Gepotidacin: Redefining Antibiotic Discovery for Translation

  2026-06-29

  This thought-leadership article explores how Gepotidacin (GSK2140944), a first-in-class triazaacenaphthylene antibiotic, provides both a mechanistic leap in bacterial DNA replication inhibition and a strategic roadmap for translational researchers. Through mechanistic insight, evidence-based protocol guidance, and forward-looking clinical context, the piece demonstrates how Gepotidacin enables not just robust antibacterial research but also a new paradigm in combatting resistance.

• JHU-083: Dissecting Glutaminase Inhibition in Neuro-Redox Di

  2026-06-28

  Explore the unique role of JHU-083, a 6-diazo-5-oxo-L-norleucine precursor, in dissecting glutaminase pathway dynamics and neuro-redox interplay. This in-depth guide reveals advanced assay strategies and integrates new mechanistic findings to empower next-generation glutamate excitotoxicity research.

• KG-501: Precision Disruption of CREB-CBP Networks in Cancer

  2026-06-27

  Explore how KG-501, a selective transcriptional coactivator disruptor, advances cancer research through targeted CREB-CBP inhibition and gene regulation. This article uniquely deciphers assay design and translational insights for oncogenic pathway analysis.

• Imatinib Hydrochloride in Cancer Research: Applied Protocols

  2026-06-26

  Imatinib hydrochloride (STI571 hydrochloride) is the gold-standard multi-target tyrosine kinase inhibitor, enabling precise dissection of oncogenic signaling in CML and GIST studies. This guide translates fresh mechanistic insights and advanced workflows into actionable, reproducible strategies for high-impact cancer research.

• Pravastatin Sodium: Transporter Biology and Advanced Applica

  2026-06-26

  Explore the molecular specificity of Pravastatin sodium as a selective HMG-CoA reductase inhibitor, with a spotlight on transporter biology, cholesterol biosynthesis inhibition, and practical assay considerations. This article provides a deeper mechanistic and translational perspective distinct from existing content.

• Minocycline HCl: Microglial Modulation and Retinal Disease R

  2026-06-25

  Explore how Minocycline HCl, a primary neuroprotective and anti-inflammatory agent, modulates microglial activity in retinal disease models. This article offers a unique, in-depth analysis of its role in amyloid clearance and experimental design, building on the latest preclinical findings.

16550 records 1/1104 page Next 12345 下5页 Last page